DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022" report to their offering.
The global age-related macular degeneration market accounted for revenue of $5,335.7 million in 2015, and it is expected to grow at a CAGR of 7.6% during 2016 - 2022. Among the various types, the wet AMD segment is expected to witness the faster growth during the forecast period. The global age-related macular degeneration market is growing at a significant rate, due to growing geriatric population, and increasing prevalence of age-related macular degeneration. In addition, increasing prevalence of lifestyle associated diseases such as obesity and hypertension, increasing healthcare expenditure and increasing pipeline drugs for AMD are also driving the growth of the global age-related macular degeneration market.
Some of the key companies operating in the global age-related macular degeneration market include Novartis AG, F. Hoffmann-La Roche Ltd., Bayer AG, Regeneron Pharmaceutical, Inc., Acucela, Ophthotech Corporation, Neurotech Pharmaceuticals, Inc., GlaxoSmithKline plc, StemCells Inc and Alimera Sciences, Inc.
Key Topics Covered:
1. Research Scope And Methodology
4.Drug Approval Process In The U.S. And Eu
5.Global AGe-Related Macular Degeneration Market Size And Forecast (2012-2022)
6.Global AGe-Related Macular Degeneration Market, By Type
7.Global AGe-Related Macular Degeneration Market, By Geography
8.Competitive Positioning Analysis
9.Company Profiles And Strategic Developments
For more information about this report visit http://www.researchandmarkets.com/research/6925q7/global